Alaunos Therapeutics, Inc. (TCRT) NASDAQ
2.76
-0.11(-3.83%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.76
-0.11(-3.83%)
Currency In USD
| Previous Close | 2.87 |
| Open | 2.76 |
| Day High | 2.76 |
| Day Low | 2.76 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.67 |
| Volume | 337 |
| Average Volume | 15,817 |
| Market Cap | 6.74M |
| PE | -1.3 |
| EPS | -2.12 |
| Moving Average 50 Days | 2.76 |
| Moving Average 200 Days | 2.89 |
| Change | -0.11 |
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
GlobeNewswire Inc.
Mar 02, 2026 11:30 AM GMT
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvements in select biomarkers associated with liver injur